Prof G
gavingiovannoni.bsky.social
Prof G
@gavingiovannoni.bsky.social
Gavin Giovannoni is a neurologist in the Faculty of Medicine at Queen Mary University of London. His current research is focused on the Epstein-Barr virus as a possible cause of multiple sclerosis. Gavin is an active MS blogger.
#MS_Selfie Q&A 123: treating MS over the age of 70

If I were over 70 and had MS, I would advocate for a proactive approach to my MS treatment. Do you agree? =>
Q&A 123: treating MS over the age of 70
If I were over 70 and had MS, I would advocate for a proactive approach to my MS treatment.
gavingiovannoni.substack.com
November 11, 2025 at 11:44 AM
#MS_Selfie Breaking News: Fenebrutinib Press Release

My predictions may be correct. What were yours? Is this the game-changer we were hoping for? => gavingiovannoni.substack.com/p/breaking-n...
Breaking news: Fenebrutinib Press Release
My predictions may be correct.
gavingiovannoni.substack.com
November 11, 2025 at 7:34 AM
#MS_Selfie Newsletter: Are you aware of SAW? Would you want to know if you had smouldering MS?

I am acutely aware of how often you have been gaslit when it comes to smouldering MS. Please share your experiences => buff.ly/xKWBbf4
Are you aware of SAW? Would you want to know if you had smouldering MS?
I am acutely aware of how often you, as people with MS or a spouse, partner or family member of someone with MS, have been gaslit when it comes to smouldering MS.
gavingiovannoni.substack.com
November 2, 2025 at 6:06 PM
#MS_Selfie Q&A 122: Comorbid Graves disease

Another option is teriflunomide, which does not cause chronic immunosuppression and may help your Graves orbitopathy. buff.ly/5Jfzz2H
Q&A 122: Comorbid Graves disease
Another option is teriflunomide, which does not cause chronic immunosuppression and may help your Graves orbitopathy.
gavingiovannoni.substack.com
October 31, 2025 at 7:14 AM
#MS_Selfie Q&A 121: Is ofatumumab superior to ocrelizumab?

Ocrelizumab showed a trend toward statistical significance, but didn’t make the final cut. Does this mean ofatumumab is superior to ocrelizumab? What do you think? =>
Q&A 121: Is ofatumumab superior to ocrelizumab?
Ocrelizumab showed a trend toward statistical significance, but didn’t make the final cut. Does this mean ofatumumab is superior to ocrelizumab?
gavingiovannoni.substack.com
October 29, 2025 at 11:44 AM
# MS_Selfie Newsletter - MS and divorce

If I were to design a comprehensive MS service, I would ensure that relationship counselling was part of the core services we offer. Do you agree? => gavingiovannoni.substack.com/p/ms-and-div...
MS and divorce
If I were to design a comprehensive MS service, I would ensure that relationship counselling was part of the core services we offer.
gavingiovannoni.substack.com
October 28, 2025 at 11:44 AM
#MS_Selfie Q&A 120: emotions and MS

Does multiple sclerosis affect your emotional state? Please help and share your experiences => buff.ly/fIRZUY2
Q&A 120: emotions
Does multiple sclerosis affect your emotional state?
gavingiovannoni.substack.com
October 26, 2025 at 3:25 AM
Will this MSARD Editorial on "When does multiple sclerosis start?" impact the field of MS and change the way we think about the disease? => www.msard-journal.com/article/S221...
When does multiple sclerosis start?
The question of when multiple sclerosis (MS) starts is not a trivial one. It has implications for primary and secondary MS prevention studies (Giovannoni et al., 2025a; Zane et al., 2025). A recent…
www.msard-journal.com
October 26, 2025 at 3:22 AM
#MS_Selfie Newsletter - Nitrofurantoin warning: please read

Nitrofurantoin is a commonly prescribed antibiotic for urinary tract infections (UTIs) and is also used long-term as a urinary antiseptic to prevent UTIs. => buff.ly/7gPsotL
Nitrofurantoin warning: please read
Nitrofurantoin is a commonly prescribed antibiotic for urinary tract infections (UTIs) and is also used long-term as a urinary antiseptic to prevent UTIs.
gavingiovannoni.substack.com
October 8, 2025 at 6:56 AM
#MS_Selfie: Which formulation of HRT would you recommend?

"It is encouraging to see these large-scale reconsiderations of the beneficial effects of HRT. However, it is upsetting that a generation of women missed out on the process.” => buff.ly/XI08YEN
Which formulation of HRT would you recommend?
"It is encouraging to see these large-scale reconsiderations of the beneficial effects of HRT. However, it is upsetting that a generation of women missed out on the process.”
gavingiovannoni.substack.com
October 6, 2025 at 8:52 AM
#MS_Selfie Q&A 118: ECTRIMS 2025 & CAR T-cells

I believe this is one of the most promising therapeutic strategies being tested in MS for several reasons: its CNS and deep tissue penetration, as well as its anti-EBV properties. => buff.ly/dE1kODU
Q&A 118: ECTRIMS 2025 & CAR T-cells
I believe this is one of the most promising therapeutic strategies being tested in MS for several reasons: its CNS and deep tissue penetration, as well as its anti-EBV properties.
gavingiovannoni.substack.com
October 3, 2025 at 7:06 AM
#MS_Selfie Q&A 117: ECTRIMS 2025 - EBV & MS

If EBV is necessary for the development of MS, why wouldn't we consider including EBV serology as part of the MS diagnosis? => buff.ly/h5QHqgM
Q&A 117: ECTRIMS 2025 - EBV & MS
If EBV is necessary for the development of MS, why wouldn't we consider including EBV serology as part of the MS diagnosis?
gavingiovannoni.substack.com
October 2, 2025 at 4:09 PM
#MS_Selfie ECTRIMS 2025: blowing my own horn

The highlight of the meeting was my presentation of the ocrelizumab results in the PPMS O’HAND study, which were positive. buff.ly/EWHOuBw
ECTRIMS 2025: blowing my own horn
The highlight of the meeting was my presentation of the ocrelizumab results in the PPMS O’HAND study, which were positive.
gavingiovannoni.substack.com
September 29, 2025 at 3:28 PM
#MS_Selfie Q&A 116: Which antiviral?

There is a fine line between being an innovator and a quack. The observational data strongly support moving forward with EBV antiviral strategies in MS .... buff.ly/8CaFvBv
Q&A 116: which antiviral?
There is a fine line between being an innovator and a quack. The observational data strongly support moving forward with EBV antiviral strategies in MS ....
gavingiovannoni.substack.com
September 19, 2025 at 1:51 AM
What a journey for people with MS and their HCPs. Natalizumab has taught us a great deal about MS. We try to tell the story in this review paper => buff.ly/WWjC7Ql
September 18, 2025 at 4:49 AM
#MS_Selfie - Prof G's response to the AI-generated newsletter
Prof G's response to the AI-generated newsletter
One of Gemini’s scotomas (blind spots) was the lack of mention of a systemic or local toxin driving MS pathology.
gavingiovannoni.substack.com
September 17, 2025 at 9:44 AM
#MS_Selfie Q&A 115: AHSCT or not?

Anxiety and uncertainty are not good bedfellows when considering treatment options for multiple sclerosis. Should this young woman have the option of AHSCT? => buff.ly/e7bwckp
Q&A 115: AHSCT or not?
Anxiety and uncertainty are not good bedfellows when considering treatment options for multiple sclerosis.
gavingiovannoni.substack.com
September 15, 2025 at 2:34 PM
#MS_Selfie: How useful is AI-generated content in the field of MS?

I have been having a back-and-forth argument with colleagues about the value of AI in MS research. I therefore asked Google Gemini Pro 2.5 Deep Research the following question: ... -> buff.ly/v3ot0m6
How useful is AI-generated content in the field of MS?
I have been having a back-and-forth argument with colleagues about the value of AI in MS research. I therefore asked Google Gemini Pro 2.5 Deep Research the following question:
gavingiovannoni.substack.com
September 13, 2025 at 11:49 AM
#MS_Selfie Q&A 114: Muscle loss and sarcopenia on GLP-1 receptor agonists

If you have been prescribed a GLP-1 RA, did your HCP assess your muscle function at baseline and provide you with information about how to prevent muscle loss? Are you having regular assessments? => buff.ly/qn6S9wI
Q&A 114: Muscle loss and sarcopenia on GLP-1 receptor agonists
If you have been prescribed a GLP-1 RA, did your HCP assess your muscle function at baseline and provide you with information about how to prevent muscle loss? Are you having regular assessments?
gavingiovannoni.substack.com
September 12, 2025 at 9:20 AM
#MS_Selfie Q&A 113: Should I take creatine supplements?

If you have started taking creatine, have you noted any impact on your MS symptoms, level of functioning and quality of life? => buff.ly/LumDjFy
Q&A 113: Should I take creatine supplements?
If you have started taking creatine, have you noted any impact on your MS symptoms, level of functioning and quality of life?
gavingiovannoni.substack.com
September 11, 2025 at 8:16 AM
#MS_Selfie - Energy drinks vs. Coffee

Are you self-medicating MS-related symptoms using energy drinks or coffee? => buff.ly/2CGG9Za
Energy drinks vs. Coffee
Are you self-medicating MS-related symptoms using energy drinks or coffee?
gavingiovannoni.substack.com
September 10, 2025 at 10:09 AM
#MS_Seflie Q&A 111 (a Nelson): Glucagon-like peptide-1 receptor agonists (GLP-1RAs)

Should I start tirzepatide or semaglutide to treat my MS? => buff.ly/OueDpzp
Q&A 111: Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Should I start tirzepatide or semaglutide to treat my MS?
gavingiovannoni.substack.com
September 4, 2025 at 12:36 PM
DR KRISTEN KRYSKO WINS 2025 RACHEL HORNE PRIZE FOR WOMEN’S RESEARCH IN MULTIPLE SCLEROSIS
DR KRISTEN KRYSKO WINS 2025 RACHEL HORNE PRIZE FOR WOMEN’S RESEARCH IN MULTIPLE SCLEROSIS
Women's Health & Research MS is finally getting the recognition it deserves.
gavingiovannoni.substack.com
September 3, 2025 at 5:16 PM